FDA Inspection 911090 — Nashat Y. Gabrail, M.D.

Nashat Y. Gabrail, M.D. — FEI 3005567620

The FDA completed an inspection of Nashat Y. Gabrail, M.D. on January 21, 2015 in Canton, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 21, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Canton, OH (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance